News

New research reveals prostate cancer survivors face a significant long-term risk of developing a third primary cancer, with a ...
Spatial transcriptomics may transform prostate cancer research by mapping immune cell localization and gene expression in ...
Astellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...
Discover a study that also highlighted that treatment intensification with enzalutamide benefited patients regardless of ...
In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...
Former United States president Joe Biden has been forced to clarify his cancer timeline following the Donald Trump cover-up ...
HBCU Legends dives into the pulse of HBCU sports—covering everything from breaking health news and prostate cancer awareness ...
Ed Burgess, diagnosed with stage IV prostate cancer, shares his journey of survival thanks to a combination of hormone therapy and the drug enzalutamide, highlighting the personal impact of research ...